The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S

Related Articles
Exercises that Help with Digestion
Healthy digestion depends on interconnected organs that work together to breakdown the food you eat into nutrients that are used by the body for energy, repair, and growth. According to research studies, about 70 million people experience problems with... Read More
Dr. Miller On KBCD - How To Prevent A Future Hospital Stay
“By Karin McCay | November 5, 2020 at 10:32 PM CST – Updated November 5 at 10:33 PM LUBBOCK, Texas (KCBD) – Last year, about 8% of adults in this country delayed or neglected medical care because of the cost. This... Read More